WALL, NJ — (Marketwired) — 04/10/15 — BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies and secure device-to-cloud mobile credentialing and identity verification solutions, announced that the companies healthcare partners will be highlighting BIO-key solutions at the HIMSS 2015 event April 12th – 16th to be held at the McCormick Center in Chicago, Illinois. Over 35,000 healthcare IT professionals will attend the four day educational and networking event.
This year, attendees can learn about BIO-key–s flexible authentication options for accessing electronic health records and achieving compliant two-factor authentication for EPCS by visiting one of the company–s healthcare partner booths. BIO-key–s healthcare partner program continues to expand and our solutions will be highlighted at the Allscripts booth #3521, Aventura booth #3080, CA Technologies booth #5538, Caradigm booth #7307, HealthCast booth #7320, IBM booth #1425, KSI Keyboards booth #3253 and RFIDeas Solutions booth #2084. BIO-key also integrates with solutions from Epic as well as Lumidigm® biometric readers from HID Global.
The foundation of BIO-key–s suite of authentication solutions for healthcare is championed by the company–s NIST evaluated fingerprint biometric software. BIO-key–s WEB-key 3.5 platform offers adaptive authentication options to support Prox Cards, Token–s and Challenge Response – Knowledge Based Questions. WEB-key can also work side by side with One Time Passwords (OTP).
“We continue to see a strong interest in our authentication solutions for healthcare as evidenced by our growing partner network,” stated Mike DePasquale, BIO-key Chairman and CEO. “As federal and state mandates for EPCS and secure access to patient information spread across the nation, hospitals and clinics along with physicians and nurses appreciate the benefits that BIO-key technology delivers. For the provider we offer the convenience of one touch authentication, for the organization we provide an unparalleled level of security and efficiency, for the patient, we offer additional time for treatment and care; so the benefits are universal.”
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key–s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world–s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key–s technology is offered directly or by market leading partners around the world. ()
Certain statements contained in this press release and in other public statements by the Company and Company officers include or may contain certain forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “will,” “may,” “future,” “plan,” “intend” and “expect” and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; delays in the development of products and statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Jay Meier
VP Corporate Development
BIO-key Intl., Inc.
651-789-6116
You must be logged in to post a comment Login